SCHEMBL29640432

SCHEMBL29640432

COc1ccc(C#Cc2cccc(O)c2O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.58
KCNH2 Q12809 2/20 0.50
PDE4D Q08499 1/20 0.47
RELA Q04206 1/20 0.46
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SLC16A3 O15427 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
ACACB O00763 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4277648 0.81 CA2 (0.50) KCNH2KDM4EALDH1A1HPGDLMNA
SCHEMBL29640438 0.81 TP53 (0.50) APPKDM4EALDH1A1HPGDLMNA
SCHEMBL28308740 0.80 APP (0.61) APPKCNH2PDE4DSLC16A3ACACB
SCHEMBL26136055 0.79 APP (0.61) APPKCNH2PDE4DKDM4ELMNA
SCHEMBL951002 0.78 ALDH1A1 (0.50) APPKCNH2KDM4EALDH1A1HPGD
SCHEMBL4148206 0.77 ALDH1A1 (0.41) APPKDM4EALDH1A1HPGDLMNA
SCHEMBL18130115 0.77 FFAR1 (0.40) KDM4EALDH1A1HPGDLMNATP53
SCHEMBL18130071 0.77 KCNH2 (0.44) KCNH2KDM4EALDH1A1HPGDLMNA
SCHEMBL10300057 0.75 APP (0.77) APPKCNH2KDM4EALDH1A1CYP3A4
SCHEMBL674764 0.75 APP (0.77) APPKCNH2KDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3280402-B1 TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING BIOMENDICS LLC (US) 2024-06-05 EP disclosed
US-11786481-B2 Formulation and process for modulating wound healing BioMendics, LLC (US) 2023-10-17 US disclosed
US-20220296538-A1 Substituted Tolans for the Modulation of Microbial Colonization BioMendics, LLC (US) 2022-09-22 US disclosed
US-11351126-B2 Substituted tolans for the modulation of microbial colonization BioMendics, LLC (US) 2022-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11786481-B2 Formulation and process for modulating wound healing SQSTM1, ATG7, TFEB APP 4010/4885KCNH2 4241/4885PDE4D 2746/4885
US-11351126-B2 Substituted tolans for the modulation of microbial colonization LMAN1, DPM1, DSTN APP 3466/4885KCNH2 3056/4885PDE4D 2221/4885
US-20220296538-A1 Substituted Tolans for the Modulation of Microbial Colonization LMAN1, DPM1, DSTN APP 3466/4885KCNH2 3056/4885PDE4D 2221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.